While individual responses vary, our Bayside Hills clientele typically report measurable improvements after just two to three sessions
Common side effects of GLP-1 agonists While patients generally tolerate GLP-1 agonists well, some may experience side effects, especially when starting treatment
The Gut-Skin Axis: A Foundational Link This is, without a doubt, the most compelling argument
compounded under Section 503A for individual prescriptions Hepatic impairment data / no controlled pharmacokinetic studies in liver disease populations Copper clearance / 85-95% of circulating copper is bound to ceruloplasmin, which is synthesized exclusively in the liver [1] Wilson disease parallel / hepatic copper accumulation can reach 250+ mcg/g dry weight in impaired biliary excretion [2] Child-Pugh A / may proceed with standard dosing and baseline copper labs Child-Pugh B / dose reduction recommended with monthly copper monitoring Child-Pugh C / use generally not recommended due to impaired biliary copper excretion Standard compounded dose / 1-2 mg subcutaneously daily or 3 times weekly Key monitoring labs / serum copper, ceruloplasmin, 24-hour urine copper, liver function tests What Is GHK-Cu and How Does It Work
Most patients begin noticing appetite suppression within the first few weeks, though maximum weight loss typically occurs after several months of treatment
This is why it is so important to set realistic expectations before beginning injections